用于癌症的纳米药物以自调节的向治疗为目标
Ketai He1,2, Mingkun Chen2, Jiao Liu3
1Department of Neurology, Joint Research Institution of Altitude Health, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in immunology
|January 19, 2024
概括
纳米医学技术利用纳米颗粒来调节癌症治疗的自. 这些纳米材料可以输送药物或诱导细胞死亡,为抑制瘤进展提供了一个有希望的方法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 自是一种细胞降解过程,与癌症的发展和进展密切相关.
- 纳米粒子具有独特的特性,使其在疾病诊断,药物输送和开发中具有价值.
- 纳米医学技术在增强癌症治疗策略方面越来越有前途.
研究的目的:
- 审查自在瘤治疗中的作用.
- 专注于在癌症治疗中应用具有自调节功能的纳米材料.
- 探索如何利用纳米材料调节自以改善癌症治疗结果.
主要方法:
- 关于自,癌症和纳米医学应用的现有文献的审查.
- 分析各种纳米粒子类型 (脂质体,,聚合物,金属基,碳基) 用于药物输送和自调节.
- 讨论纳米材料影响癌细胞自的机制.
主要成果:
- 纳米材料可以作为自调节者的向载体,通过防止药物分解来增强化疗效.
- 某些纳米材料可以诱导自,导致氧化应激和亡,从而抑制癌细胞的进展.
- 脂质体是临床上最常用的纳米粒子,其他材料类型的优化正在进行中.
结论:
- 纳米材料在癌症治疗中提供了调节自的多功能策略.
- 有针对性的输送自调节剂和诱导自中介细胞死亡是关键的应用.
- 不同纳米材料的持续开发为推进瘤治疗提供了重大潜力.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
Delivery Pathways to the Lysosome
6.6K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


